Drugmaker Teva hires Lundbeck CEO Schultz to restore its health
Teva CEO Sees a Final Opioid Settlement Coming This Year | Barron's
Bristol-Myers Squibb CEO Giovanni Caforio, Teva Pharmaceuticals CEO Kare Schultz, and Celgene Corporation former CEO Mark Alles are sworn in prior to testifying by video conference during a hearing before the US
Kåre Schultz new CEO of Teva - Nordic Life Science – the leading Nordic life science news service
Teva plans innovative medical products to expand presence in China - Chinadaily.com.cn
Teva CEO on decimated share price: "It's rational enough from a market point of view"
Kåre Schultz - Disability:IN
Teva CEO Kare Schultz's pay fell in 2021 - Globes
Teva Names Kåre Schultz as President and Chief Executive Officer » FINCHANNEL
Danish Top Manager in Israeli Teva stands for key role in vaccine cooperation | News Infinitum
Teva CEO Kare Schultz Says Drugmaker Will Fight US Price-Fixing Charges - Bloomberg
Teva Names Kare Schultz as President and Chief Executive Officer - Pharmaceutical Processing World
A Look At Kare Schultz, The New CEO In Charge Of Teva
Israel's Teva Pharma appoints H Lundbeck's Kare Schultz as CEO | Pharma, Teva, Teva pharmaceuticals
Serial Problem Solver
Marianne Nouwens (@MarianneNouwens) / Twitter
Teva finally announces successful CEO appointment | Pharmafile
Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth | Ctech
Teva CEO: We have to launch new products - Globes
Kare Schultz | CHEManager
Teva sees higher margins, lower debt from restructuring | Financial Times
Does Teva Really Have $5 Billion In Debt Payments Due Next Year? (NYSE:TEVA) | Seeking Alpha
